GP-Act III Acquisition Q4 2025 Earnings Report

GP-Act III Acquisition EPS Results

• Actual EPS: $0.08
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

GP-Act III Acquisition Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

GP-Act III Acquisition Announcement Details

• Quarter: Q4 2025
• Date: 3/26/2026
• Time: After Market Closes
• Conference Call Date: N/A
• Conference Call Time: N/A

GP-Act III Acquisition (NASDAQ:GPAT) Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries. Upon the completion of its initial public offering, GP-Act III Acquisition Corp placed the net proceeds in a trust account, which will be used to fund and complete a qualifying business combination with a private company.

GP-Act III Acquisition Corp intends to evaluate potential targets both within the United States and in certain select international markets. The company is not limited to a geographic region and may pursue opportunities in jurisdictions where it can provide strategic, operational or financial support to a merged entity.

The company’s board of directors and management team are led by experienced financial and corporate executives who specialize in mergers and acquisitions, private equity investing and capital markets transactions. They are supported by advisors with backgrounds in deal sourcing, due diligence and corporate governance. As of now, GP-Act III Acquisition Corp has not announced a definitive agreement for a business combination.